The Behavioral Rehabilitation Market is projected to reach US$ 540.84 million by 2028 from US$ 350.63 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.   Drug manufacturers play a critical role in introducing new products to cope with the global market's demands. For instance, in May 2021, Lybalvi (olanzapine and samidorphan), an atypical antipsychotic...